Food and Drug Administration (FDA) Act of 2009 (Republic Act No. 9711).
Country
Type of law
Legislation
Abstract
This Act aims to protect and promote the right to health of the Filipino people and to establish and maintain an effective health products regulatory system.
This Act created the Food and Drug Administration in the Department of Health to replace the Bureau of Food and Drugs.
The Act amends the Food, Drug and Cosmetic Act (Republic Act No. 3720). Amendments include: substitution of provisions of section 4 and insertion of new subsections 4(h) to 4(q) on powers, functions and duties of the FDA; insertion of new subsections 5(a)(1)-5(a)(4), 5(b)(1)-5(b)(3) and 5(c)-5(f) on the establishment of new centres and field offices; insertion of new subsections 6(a)- 6(i) on the internal organization of the FDA; minor changes to section 7; substitution or insertion of new definitions in section 10; substitution of various subsections of section 11 on restrictions on the manufacture, import, export, etc. of health products; substitution of various provisions of section 12 on penalties for whoever violates provisions of section 11; minor changes to section 26 on rule and regulation making powers of the Secretary of Health; insertion of a new section 29A on administrative sanctions; insertion of a new heading and of new sections 30 to 33 on additional powers and functions of the Director-General; the renumbering of section 30 and therefore the renumbering of the subsequent sections; substitution of section 31 with a new section 34 on fees and other incomes of the FDA; and the insertion of a new Chapter XIV providing for testing laboratories and field offices.
This Act created the Food and Drug Administration in the Department of Health to replace the Bureau of Food and Drugs.
The Act amends the Food, Drug and Cosmetic Act (Republic Act No. 3720). Amendments include: substitution of provisions of section 4 and insertion of new subsections 4(h) to 4(q) on powers, functions and duties of the FDA; insertion of new subsections 5(a)(1)-5(a)(4), 5(b)(1)-5(b)(3) and 5(c)-5(f) on the establishment of new centres and field offices; insertion of new subsections 6(a)- 6(i) on the internal organization of the FDA; minor changes to section 7; substitution or insertion of new definitions in section 10; substitution of various subsections of section 11 on restrictions on the manufacture, import, export, etc. of health products; substitution of various provisions of section 12 on penalties for whoever violates provisions of section 11; minor changes to section 26 on rule and regulation making powers of the Secretary of Health; insertion of a new section 29A on administrative sanctions; insertion of a new heading and of new sections 30 to 33 on additional powers and functions of the Director-General; the renumbering of section 30 and therefore the renumbering of the subsequent sections; substitution of section 31 with a new section 34 on fees and other incomes of the FDA; and the insertion of a new Chapter XIV providing for testing laboratories and field offices.
Attached files
Web site
Long title of text
An Act strengthening and rationalizing the regulatory capacity of the Bureau of Food and drugs (BFAD) by establishing adequate testing laboratories and field offices, upgrading its equipment, augmenting its human resource complement, giving authority to retain its income, renaming it the Food and Drug Administration (FDA), amending certain sections of Republic Act No. 3720, as amended, and appropriating funds thereof.
Date of text
Entry into force notes
This Act enters into force 15 days after its publication in the Official Gazette.
Repealed
No
Source language
English
Legislation Amendment
No